T o assess the contribution of a new diagnostic test, a hierarchical model of efficacy was proposed by Fryback and Thornbury (1) .
Although the model was developed for the evaluation of diagnostic imaging, its parameters also apply to "physiological imaging," with its attributes of: 1) technical quality; 2) diagnostic accuracy; 3) diagnostic thinking efficacy; 4) effect on therapy; 5) patient's outcome; and 6) economic aspects (Central Illustration). A key feature of this model is that for a test to be efficacious at a higher level in this hierarchy, it must be efficacious at lower levels.
Since the first description of pressure wire-based fractional flow reserve (FFR) (2) (3) (4) , an abundance of data pertaining to each of these criteria have been reported. Accordingly, FFR is now considered to be the reference standard for the evaluation of the ischemic potential and the expected benefit from revascularization of coronary stenosis (5) (6) (7) (8) . Moreover, FFR is increasingly being used in clinical trials as an inclusion criterion or as an endpoint (9) and to validate new diagnostic modalities (10, 11) . Although FFR is calculated from distal coronary pressure (P d ) and aortic pressure (P a ) obtained during maximal coronary hyperemia. In principle, these measurements are straightforward and almost fully automated, as illustrated in Figure 1 . Yet, minor differences among practices of different laboratories have led to some heterogeneity in acquiring and interpreting the data.
Because FFR-based decisions are important for patients' outcomes, and given the need for rigor and reproducibility in reading the tracings by core laboratories, the highest technical quality of FFR measurements is desirable. As FFR by itself is a highly reproducible diagnostic measure, deviations mainly derive from a lack of standardization (12 Fractional Flow Reserve storing the pressure tracings for daily practice and for the purpose of clinical research through a core laboratory. Comprehensive reviews of the principle of FFR and of the FFR-based clinical outcome data have been described previously (13, 14) .
PATIENTS AND VESSEL SELECTION
In clinical practice, 2 groups of patients undergo FFR assessment.
STABLE CORONARY DISEASE.
In patients with signs suggesting stable coronary artery disease, the European Guidelines support FFR measurements with a Class IA recommendation for the evaluation of stenoses ranging between 50% to 90% diameter stenosis (by visual estimate of coronary angiogram) and when noninvasive ischemia testing is contraindicated, nondiagnostic, or not available (15) . Recent data indicate that even lesions of <50% by quantitative coronary angiography can be hemodynamically significant (16) . Their precise characterization by physiological measurements is desirable when located in proximal coronary segments that supply a large myocardial mass, because they may have prognostic significance (17, 18) . Therefore, it seems advisable to perform FFR measurements more on clinical grounds than on strict angiographic criteria, especially in the case of atypical symptoms or contradictory noninvasive and invasive findings. Archiving this information (as well as intravascular ultrasound and optical coherence tomography, when available) side-by-side, in a format that is easily accessible ("same place, same time" principle) enables surgeons, interventional cardiologists, clinicians, and heart team meeting participants to be exposed to these different imaging modalities and to integrate "anatomy" and "physiology" into individual clinical decision making. CRA ¼ cranial; DICOM ¼ digital imaging and communications in medicine; ECG ¼ electrocardiogram; FFR ¼ fractional flow reserve; LAO ¼ left anterior oblique; P a ¼ aortic pressure; P d ¼ distal coronary pressure. 
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This also applies to patients with non-ST-segment elevation myocardial infarction (19) . Moreover, in these patients, the presence of angiographic multivessel disease is frequent (20) , and when present, HEART FAILURE. Calculation of FFR considers the central venous pressure as negligibly low compared with the arterial values; therefore, its value is not incorporated in the formula. Recent data verified the validity of this concept, even in patients with pathologically elevated filling pressures. Therefore, the measured FFR value can also be considered accurate in patients with heart failure, and the incorporation of right atrial pressure is not indicated in any circumstances (25) .
MATERIALS AND PRACTICALITIES
Considering that intracoronary manipulations are needed for FFR measurements, proper anticoagulation (i.e., $50 U/kg unfractionated heparin) is mandatory.
Also, full vasodilation of the epicardial artery by intracoronary administration of nitrates (200 mg isosorbide mononitrate) should be done routinely.
These steps should not deviate from those routinely applied for any PCI or coronary imaging procedure.
FIGURE 1 Typical Example of FFR Measurement Obtained After Intracoronary Bolus Injection of Adenosine
The injection of the bolus is brief so that the aortic signal (red) is interrupted during no longer than 1 to 2 s. Automated calculation of FFR corresponds to the ratio of mean distal coronary pressure (green) to mean aortic pressure during maximal hyperemia. CRA ¼ cranial;
FFR ¼ fractional flow reserve; LAO ¼ left anterior oblique; P a ¼ aortic pressure; P d ¼ distal coronary pressure. 
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To obtain FFR values, a catheter, a pressuremeasuring guidewire, and a hyperemic agent are needed.
CATHETERS. G u i d i n g c a t h e t e r s . Any size of guiding catheter can be used. However, it is important to realize that, depending on the relative size of the guiding catheter and the coronary ostium, the presence of the catheter can impede coronary flow ( Figure 2 ). Impeded flow can be detected by ventricularization of the P a signal, which becomes apparent predominantly during hyperemia. This phenomenon will falsely increase the FFR value, and thus underestimate the degree of myocardial ischemia. Therefore, it is critical to pay close attention to the morphology of the aortic pressure tracing and to slightly disengage the guiding catheter immediately upon induction of hyperemia. Another potential pitfall is damping of the aortic waveform by residual contrast material in the guiding catheter.
This occurs more frequently in smaller catheters (i.e., 5-F), and can be easily remedied by flushing the guiding catheter with saline prior to FFR measurements. Ideally, the dicrotic notch should be discernable on the aortic waveform to verify an adequate pressure tracing.
G u i d i n g c a t h e t e r s w i t h s i d e h o l e s . Their use is
not recommended for FFR measurements. The pressure signal obtained through these catheters does not reflect the pressure proximal to the stenosis, but rather reflects a mix between the coronary pressure (through the distal end) and the P a (through the side holes). However, if the usage of a catheter with side holes is needed for clinical reasons, measurements should be performed with intravenous adenosine administration and with the guiding catheter disengaged from the coronary ostium. This is a 0.014-inch pressure-measuring guidewire, equipped with an electric pressure sensor 3 cm from the tip, at the junction between radiopaque and nonradiopaque portions of the wire. It can be used as a regular guidewire when PCI becomes indicated. It is available in 2 versions that are connected with either a rotational (PrimeWire Prestige) or clip (Verrata) attachment to the console. 3 . OptoWire (Opsens Medical, Quebec, Quebec, Canada). This is a 0.014-inch pressure-measuring guidewire, equipped with a fiber optic pressure In daily practice, it is recommended to always use the same means of producing hyperemia. This routine simplifies the process, increases familiarity among staff and operators, and thereby minimizes errors.
PRACTICALITIES OF FFR MEASUREMENTS
For the sake of standardization, a systematic step-bystep procedure can be proposed (34) . As there are minor differences between the different commercially available systems, the manufacturer's instructions should be followed. To create a routine and to minimize the risk of errors, it is advisable to become familiar with 1 commercially available system in a catheter laboratory. (Figure 3) .
With intracoronary adenosine, it is convenient to use a 10-ml syringe filled with 200 mg of adenosine. For the right coronary artery, 5 ml (100 mg in total) and for the left coronary artery 10 ml (200 mg in total) are briskly injected (29) . After the adenosine is (Figure 4) . The short-lasting effect of intracoronary adenosine allows these measurements to be made in duplicate without losing more than 1 min. A second hyperemic stimulus can then be given and the exact same tracing recorded. Because the test/retest repeatability of FFR is very high (12) , the variation between the 2 consecutive values should be minimal.
These duplicate measurements are therefore the first quality check for the FFR measurements.
The advantage of always recording for the same length of time is that the tracings become immediately recognizable, even for noninterventional cardiologists, as well as for core laboratory purposes. Toth et al.
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QUALITY ASSURANCE FOR
FFR MEASUREMENTS
FFR is increasingly being used in scientific trials as an inclusion criterion or as a study endpoint (9) , as well as to validate new diagnostic modalities (10, 11) .
In many of these trials, akin to most other metrics, 
